J. Bonneterre

845 total citations
18 papers, 616 citations indexed

About

J. Bonneterre is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, J. Bonneterre has authored 18 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in J. Bonneterre's work include Brain Metastases and Treatment (6 papers), Cancer Treatment and Pharmacology (5 papers) and Breast Cancer Treatment Studies (4 papers). J. Bonneterre is often cited by papers focused on Brain Metastases and Treatment (6 papers), Cancer Treatment and Pharmacology (5 papers) and Breast Cancer Treatment Studies (4 papers). J. Bonneterre collaborates with scholars based in France, Poland and Germany. J. Bonneterre's co-authors include J. J. Bonerandi, Marie‐Françoise Avril, Jean‐Jacques Grob, Jozef Šufliarský, Steinar Aamdal, Philippe Saïag, Peter Mohr, K. Neuber, Thomas Bieber and Alexander Scherrer and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

J. Bonneterre

18 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Bonneterre France 8 394 330 136 117 63 18 616
S. Pezzulli United States 10 352 0.9× 403 1.2× 94 0.7× 104 0.9× 34 0.5× 19 704
Teresa Puértolas Spain 9 291 0.7× 147 0.4× 127 0.9× 117 1.0× 62 1.0× 29 499
Peter Cheverton United Kingdom 11 313 0.8× 245 0.7× 137 1.0× 52 0.4× 45 0.7× 18 529
Alessandra Bulotta Italy 14 406 1.0× 264 0.8× 249 1.8× 82 0.7× 52 0.8× 47 695
Austin J. Combest United States 9 290 0.7× 213 0.6× 198 1.5× 43 0.4× 76 1.2× 19 565
Andrea Milani Italy 12 416 1.1× 268 0.8× 208 1.5× 109 0.9× 24 0.4× 35 765
Nicoletta Staropoli Italy 14 350 0.9× 233 0.7× 112 0.8× 80 0.7× 45 0.7× 42 617
E. Ruth Plummer United Kingdom 13 210 0.5× 229 0.7× 74 0.5× 37 0.3× 64 1.0× 20 470
Jingcao Huang China 16 369 0.9× 515 1.6× 111 0.8× 73 0.6× 54 0.9× 51 907
Cristina Nieto‐Jiménez Spain 16 464 1.2× 456 1.4× 139 1.0× 181 1.5× 63 1.0× 40 942

Countries citing papers authored by J. Bonneterre

Since Specialization
Citations

This map shows the geographic impact of J. Bonneterre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Bonneterre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Bonneterre more than expected).

Fields of papers citing papers by J. Bonneterre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Bonneterre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Bonneterre. The network helps show where J. Bonneterre may publish in the future.

Co-authorship network of co-authors of J. Bonneterre

This figure shows the co-authorship network connecting the top 25 collaborators of J. Bonneterre. A scholar is included among the top collaborators of J. Bonneterre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Bonneterre. J. Bonneterre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
3.
Rhun, Émilie Le, Nuria Kotecki, Fahed Zaïri, et al.. (2011). Prospective follow-up of 96 patients with breast cancer with leptomeningeal metastasis recruited from 2007 to 2010.. Journal of Clinical Oncology. 29(15_suppl). 2089–2089. 1 indexed citations
4.
Biver, Emmanuel, Laurence Vanlemmens, Marie-Hélène Vieillard, et al.. (2010). 376 Is arthralgia observed in patients treated with adjuvant aromatase inhibitors for breast cancer related to inflammatory rheumatism? Rheumatologic evaluation of a cohort of 36 patients. European Journal of Cancer Supplements. 8(3). 167–167. 1 indexed citations
5.
Rhun, Émilie Le, et al.. (2010). 479 Primary breast cancer phenotype associated with propensity for leptomeningeal metastases. European Journal of Cancer Supplements. 8(3). 199–199. 5 indexed citations
6.
Kotecki, Nuria, Émilie Le Rhun, Marie‐Christine Baranzelli, et al.. (2010). Pathological characteristics and prognosis of a cohort of 74 patients (pts) with breast cancer (BC) with neoplastic meningitis (NM).. Journal of Clinical Oncology. 28(15_suppl). 1123–1123. 2 indexed citations
7.
Kerbrat, Pierre, H. Roché, P. Fumoleau, et al.. (2005). Does time interval between surgery and adjuvant chemotherapy initiation modify treatment efficacy in operable, breast cancer patients? French Adjuvant Study Group (FASG) results. Journal of Clinical Oncology. 23(16_suppl). 660–660. 5 indexed citations
8.
Avril, Marie‐Françoise, Steinar Aamdal, Jean‐Jacques Grob, et al.. (2004). Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study. Journal of Clinical Oncology. 22(6). 1118–1125. 355 indexed citations
9.
Penel, Nicolas & J. Bonneterre. (2003). Thérapie génique du mélanome : synthèse des études cliniques publiées. La Revue de Médecine Interne. 24(7). 443–451. 2 indexed citations
10.
11.
Lebrun, T, et al.. (1999). [Advanced breast cancer: an evaluation of the cost of recurrence].. PubMed. 86(6). 585–90. 10 indexed citations
12.
Block, Stephan, et al.. (1998). [Granisetron (per os) compared with ondansetron (per os) in the prevention of nausea and vomiting induced by mildly emetogenic chemotherapies. Groupe de Recherches en Cancerologie du Nord].. PubMed. 85(6). 562–8. 5 indexed citations
13.
Bonneterre, J. & B Hecquet. (1995). Granisetron (IV) compared with ondansetron (IV plus oral) in the prevention of nausea and vomiting induced by moderately-emetogenic chemotherapy. A cross-over study.. PubMed. 82(12). 1038–43. 21 indexed citations
14.
Bonneterre, J., et al.. (1994). Loss of efficacy of ondansetron-dexamethasone during successive courses in female patients receiving high-dose cisplatin.. PubMed. 81(3). 219–22. 1 indexed citations
15.
Bonneterre, J., Didier Cupissol, Jean‐Jacques Grob, et al.. (1992). Fotemustine plus dacarbazine for malignant melanoma. European Journal of Cancer. 28(11). 1807–1811. 18 indexed citations
16.
Bonneterre, J., E Grosshans, P. Fumoleau, et al.. (1990). Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma. Cancer Chemotherapy and Pharmacology. 27(2). 81–84. 23 indexed citations
17.
Jacquillat, C, David Khayat, Pierre Banzet, et al.. (1990). Chemotherapy by fotemustine in cerebral metastases of disseminated malignant melanoma. Cancer Chemotherapy and Pharmacology. 25(4). 263–266. 52 indexed citations
18.
Hecquet, B, P Vennin, Charles Fournier, et al.. (1985). Platinum concentration in human tumors of head and neck, uterine cervix, and breast following treatment with cisplatin. Cancer Chemotherapy and Pharmacology. 15(3). 310–2. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Pezzulli Breakdown of academic impact, for papers by Teresa Puértolas Breakdown of academic impact, for papers by Peter Cheverton Breakdown of academic impact, for papers by Alessandra Bulotta Breakdown of academic impact, for papers by Austin J. Combest Breakdown of academic impact, for papers by Andrea Milani Breakdown of academic impact, for papers by Nicoletta Staropoli Breakdown of academic impact, for papers by E. Ruth Plummer Breakdown of academic impact, for papers by Jingcao Huang Breakdown of academic impact, for papers by Cristina Nieto‐Jiménez
Rankless by CCL
2026